Herrstedt, J., & Jordan, K. (2019). Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: A randomised, double-blind, placebo-controlled, dose-ranging trial. Supportive care in cancer, 27(7), . https://doi.org/10.1007/s00520-018-4564-8
Chicago Style (17th ed.) CitationHerrstedt, Jørn, and Karin Jordan. "Amisulpride Prevents Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Randomised, Double-blind, Placebo-controlled, Dose-ranging Trial." Supportive Care in Cancer 27, no. 7 (2019). https://doi.org/10.1007/s00520-018-4564-8.
MLA (9th ed.) CitationHerrstedt, Jørn, and Karin Jordan. "Amisulpride Prevents Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Randomised, Double-blind, Placebo-controlled, Dose-ranging Trial." Supportive Care in Cancer, vol. 27, no. 7, 2019, https://doi.org/10.1007/s00520-018-4564-8.